Pfizer Eyes Consumer Unit Spin-Off Or Sale Price North of $10 Bil.
This article was originally published in The Tan Sheet
Executive Summary
Pfizer has "no interest" in separately divesting individual products from its consumer division, CEO Hank McKinnell said during a Feb. 10 analysts presentation